(+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity onlyFRIDE, Ester; FEIGIN, Cfir; PONDE, Datta E et al.European journal of pharmacology. 2004, Vol 506, Num 2, pp 179-188, issn 0014-2999, 10 p.Article

Pharmacological and therapeutic targets for Δ⁹-tetrahydrocannabinol and cannabidiolPERTWEE, Roger G.Euphytica. 2004, Vol 140, Num 1-2, pp 73-82, issn 0014-2336, 10 p.Conference Paper

Constitutive activity of cannabinoid-2 (CB₂) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242MANCINI, I; BRUSA, R; QUADRATO, G et al.British journal of pharmacology. 2009, Vol 158, Num 1, pp 382-391, issn 0007-1188, 10 p.Article

A cannabinoid receptor 1 mutation proximal to the DRY motif results in constitutive activity and reveals intramolecular interactions involved in receptor activationD'ANTONA, Aaron M; AHN, Kwang H; LEI WANG et al.Brain research. 2006, Vol 1108, pp 1-11, issn 0006-8993, 11 p.Article

Pharmacological actions of cannabinoidsPERTWEE, R. G.Handbook of experimental pharmacology. 2005, Vol 168, pp 1-51, issn 0171-2004, 51 p.Article

Similar in vitro pharmacology of human cannabinoid CB₁ receptor variants expressed in CHO cellsJING CHEN XIAO; JEWELL, James P; LIN, Linus S et al.Brain research. 2008, Vol 1238, pp 36-43, issn 0006-8993, 8 p.Article

CB₂ receptor-mediated migration of immune cells : it can go either wayMILLER, A. M; STELLA, N.British journal of pharmacology. 2008, Vol 153, Num 2, pp 299-308, issn 0007-1188, 10 p.Article

The role of the CB₁ receptor in the regulation of sleepMURILLO-RODRIGUEZ, Eric.Progress in neuro-psychopharmacology & biological psychiatry. 2008, Vol 32, Num 6, pp 1420-1427, issn 0278-5846, 8 p.Article

Récepteurs cannabinoïdes: Fonctions cellulaires = Cannabinoid receptors : cellular functionsBOUABOULA, M; CASELLAS, P.Douleur et analgésie. 2001, Vol 14, Num 4, pp 207-211, issn 1011-288XArticle

Atypical cannabinoid stimulates endothelial cell migration via a G_i/G_o-coupled receptor distinct from CB₁, CB₂ or EDG-1FONG MING MO; OFFERTALER, Laszlo; KUNOS, George et al.European journal of pharmacology. 2004, Vol 489, Num 1-2, pp 21-27, issn 0014-2999, 7 p.Article

Endocannabinoids and the Neurochemistry of GluttonyKIRKHAM, Tim.Journal of neuroendocrinology. 2008, Vol 20, Num 9, pp 1099-1100, issn 0953-8194, 2 p.Article

Analysis of urine for 11-nor-△⁹-tetrahydrocannabinol-9-carboxylic acid using sep-PAK cartridges for sample cleanupNAKAMURA, G. R; STALL, W. J; MASTERS, R. G et al.Analytical chemistry (Washington, DC). 1985, Vol 57, Num 7, pp 1492-1494, issn 0003-2700Article

Oleamide: a member of the endocannabinoid family?FOWLER, Christopher J.British journal of pharmacology. 2004, Vol 141, Num 2, pp 195-196, issn 0007-1188, 2 p.Article

Discovery of S-444823, a potent CB1/CB2 dual agonist as an antipruritic agentODAN, Masahide; ISHIZUKA, Natsuki; YASUI, Kiyoshi et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 8, pp 2898-2901, issn 0960-894X, 4 p.Article

CB₁ and CB₂ receptor-mediated signalling: a focus on endocannabinoidsMCALLISTER, Sean D; GLASS, Michelle.Prostaglandins, leukotrienes and essential fatty acids. 2002, Vol 66, Num 2-3, pp 161-171, issn 0952-3278Article

Cannabinoid Type 1 Receptor : Another Arrow in the Adipocytes' BowBELLOCCHIO, L; CERVINO, C; VICENNATI, V et al.Journal of neuroendocrinology. 2008, Vol 20, pp 130-138, issn 0953-8194, 9 p., SUP1Conference Paper

C3-Heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptorDIXON, Darryl D; TIUS, Marcus A; THAKUR, Ganesh A et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 16, pp 5322-5325, issn 0960-894X, 4 p.Article

Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potentialSTADELMANN, Andreas M; JUCKEL, Georg; ARNING, Larissa et al.Neuroscience letters. 2011, Vol 496, Num 1, pp 60-64, issn 0304-3940, 5 p.Article

Pharmacological characterization of the cannabinoid CB₁ receptor PET ligand ortholog, [³H]MePPEPSUTER, Todd M; CHESTERFIELD, Amy K; CHUN BAO et al.European journal of pharmacology. 2010, Vol 649, Num 1-3, pp 44-50, issn 0014-2999, 7 p.Article

In vitro pharmacological characterization of AM1241 : a protean agonist at the cannabinoid CB₂ receptor?YAO, B. B; MUKHERJEE, S; FAN, Y et al.British journal of pharmacology. 2006, Vol 149, Num 2, pp 145-154, issn 0007-1188, 10 p.Article

CB₁ receptor antagonists for the treatment of nicotine addictionCOHEN, Caroline; KODAS, Ercem; GRIEBEL, Guy et al.Pharmacology, biochemistry and behavior. 2005, Vol 81, Num 2, pp 387-395, issn 0091-3057, 9 p.Conference Paper

In vitro and in vivo evaluation of ¹¹C-SD5024, a novel PET radioligand for human brain imaging of cannabinoid CB₁ receptorsTSUJIKAWA, Tetsuya; ZOGHBI, Sami S; JINSOO HONG et al.NeuroImage (Orlando, Fla.). 2014, Vol 84, pp 733-741, issn 1053-8119, 9 p.Article

Suppression by WIN55212-2, a cannabinoid receptor agonist, of inflammatory reactions in mouse car : Interference with the actions of an endogenous ligand, 2-arachidonoylglycerolOKA, Saori; WAKUI, Junichi; GOKOH, Maiko et al.European journal of pharmacology. 2006, Vol 538, Num 1-3, pp 154-162, issn 0014-2999, 9 p.Article

Cannabinoids, immune system and cytokine networkMASSI, P; VACCANI, A; PAROLARO, D et al.Current pharmaceutical design. 2006, Vol 12, Num 24, pp 3135-3146, issn 1381-6128, 12 p.Article

Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB₁ receptor antagonistWILEY, Jenny L; BREIVOGEL, Christopher S; MARTIN, Billy R et al.European journal of pharmacology. 2011, Vol 651, Num 1-3, pp 96-105, issn 0014-2999, 10 p.Article